Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 12, 2026

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

Nanomicelle-Based Multi-mRNA Delivery Promotes Cardiac Repair After Myocardial Infarction.

Kazuma Handa1, Takuji Kawamura1, Yasunobu Mano2,3

  • 1Department of Cardiovascular Surgery The University of Osaka Graduate School of Medicine Osaka Japan.

Small Science
|June 11, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis.

Nature communications·2026
Same author

Pediatric dilated cardiomyopathy caused by TNNT2-R151W mutation: Modeling and rescue in patient-derived induced pluripotent stem cells and engineered heart tissue.

Bioengineering & translational medicine·2026
Same author

Computed tomography-derived elastic modulus as a noninvasive marker of aortic wall integrity: Correlation with histopathology in the ascending aorta.

JTCVS open·2026
Same author

Human iPSC cardiomyocyte patch transplantation modifies extracellular matrix and fibroblast behavior after myocardial infarction.

iScience·2026
Same author

Hypoxia conditioned adipose-derived stem cell-derived extracellular vesicle therapy improves cardiac function in a rat model of ischemic cardiomyopathy.

Regenerative therapy·2026
Same author

Stable and functional regulatory T cell attenuates fibrotic remodeling in heart failure.

Regenerative therapy·2026
Same journal

Cost-Effective Na<sub>4</sub>Fe<sub>3</sub>(PO<sub>4</sub>)<sub>2</sub>P<sub>2</sub>O<sub>7</sub> Cathode Materials for Sodium-Ion Batteries in Large-Scale Energy Storage Applications.

Small science·2026
Same journal

Catcher Domains as Multifunctional Fusion Modules for Soluble Expression, Covalent Coupling, and Spatial Organization of Recombinant Proteins.

Small science·2026
Same journal

Three-Dimensional Characterization of the Collagen-Hydroxyapatite Interaction During Heterotopic Ossification in Healing Rat Achilles Tendons.

Small science·2026
Same journal

3D-Printed Optical Volatile Organic Compound Sensors Based on Donor-Substituted Coumarin Thermally Activated Delayed Fluorescence Emitters.

Small science·2026
Same journal

Programming Nonlinear Interfacial Mechanics of Synthetic Cells: Lipid Geometry and DNA Nanostructures.

Small science·2026
Same journal

Ink-Printed Thermoelectric Materials and Devices: Material Preparation, Fabrication Techniques, and Applications.

Small science·2026
See all related articles
This summary is machine-generated.

Synthetic messenger RNA (mRNA) therapy using a combination of five genes effectively regenerated heart tissue, improved cardiac function, and extended survival in a mouse model of myocardial infarction (MI). This combinatorial mRNA approach offers a promising new treatment for heart failure.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Molecular Therapy

Background:

  • Pathological cardiac remodeling after myocardial infarction (MI) is complex and requires multifaceted therapeutic strategies.
  • Synthetic messenger RNAs (mRNAs) offer a flexible platform for combinatorial gene delivery.
  • Extracellular vesicles from cardiomyocytes have previously shown potential in restoring cardiac function.

Purpose of the Study:

  • To investigate the therapeutic potential of a synthetic mRNA cocktail for treating post-MI heart failure.
  • To evaluate the efficacy of delivering five specific therapeutic genes via polyplex nanomicelles directly into the myocardium.
  • To elucidate the molecular mechanisms underlying mRNA cocktail-mediated cardiac repair.

Main Methods:

  • Synthetic mRNAs encoding five selected genes (Hgf, Igf1, Pdgfb, Cxcl12, Tgfβ1) were formulated into polyplex nanomicelles.
Keywords:
heart failuremultigene mRNA therapymyocardial infarctionpathological remodelingpolyplex nanomicelle

More Related Videos

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Experiment Videos

Last Updated: Jun 12, 2026

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

  • Direct myocardial administration of mRNA nanomicelles in a mouse model of MI-induced heart failure.
  • Analysis of molecular pathways including PI3K-Akt-ETV4, JNK/FOXO3, and ERK signaling.

    • Main Results:

    • The mRNA cocktail treatment promoted angiogenesis via the PI3K-Akt-ETV4 pathway.
    • Fibrosis was suppressed through inhibition of the JNK/FOXO3 pathway.
    • Cardiac repair and regeneration were enhanced by activating ERK signaling, leading to improved contractility and survival.

    Conclusions:

    • Multigene synthetic mRNA cocktail therapy demonstrates significant therapeutic potential for post-MI heart failure.
    • Polyplex nanomicelles facilitate effective local delivery and sustained expression of therapeutic mRNAs.
    • This approach represents a novel strategy for treating complex cardiac remodeling and offers a step towards new interventions for heart disease.